3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Uterine Cervical Neoplasms
7
Papillomavirus Infections
6
Neoplasms
5
Breast Neoplasms
4
Uterine Cervical Dysplasia
3
Melanoma
3
Lung Neoplasms
3
Herpes Zoster
3
Condylomata Acuminata
3
Vulvar Neoplasms
2
Prostatic Neoplasms
2
Influenza, Human
2
Anus Neoplasms
2
Wilms Tumor
1
Whooping Cough
1
Waldenstrom Macroglobulinemia
1
Vaginal Neoplasms
1
Tetanus
1
Squamous Cell Carcinoma of Head and Neck
1
Spondylitis, Ankylosing
1
Small Cell Lung Carcinoma
1
Sarcoma
1
Rheumatic Diseases
1
Recurrence
1
Psoriasis
1
Persistent Infection
1
Pancreatic Neoplasms
1
Neuroblastoma
1
Neoplasms, Glandular and Epithelial
1
Nasopharyngeal Neoplasms
1
Interventions
Carboplatin
49
Etoposide
46
Cisplatin
42
Topotecan
39
Irinotecan
21
Paclitaxel
20
Nivolumab
15
pembrolizumab
13
Gemcitabine
13
atezolizumab
11
Ipilimumab
11
durvalumab
9
Radiotherapy
9
Doxorubicin
7
Bevacizumab
7
rovalpituzumab tesirine
6
etoposide phosphate
6
amrubicin
6
Psychiatric Rehabilitation
6
PM 01183
6
Docetaxel
6
Counseling
6
trilaciclib
5
Temozolomide
5
Sunitinib
5
Platinum
5
Imatinib Mesylate
5
Cyclophosphamide
5
Bortezomib
5
130-nm albumin-bound paclitaxel
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Small Cell Lung Carcinoma
×
Vaccines
×
Clear all
NCT04487756
2026-06-02
VENEZO-LUNG
Instituto Oncológico Dr Rosell
Phase 1/2
Completed
20 enrolled